Veracyte
VCYT
149 hedge funds and large institutions have $983M invested in Veracyte in 2019 Q1 according to their latest regulatory filings, with 35 funds opening new positions, 43 increasing their positions, 54 reducing their positions, and 11 closing their positions.
218% more first-time investments, than exits
New positions opened: 35 | Existing positions closed: 11
111% more capital invested
Capital invested by funds: $465M → $983M (+$518M)
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
19% more funds holding
Funds holding: 125 → 149 (+24)
4.37% more ownership
Funds ownership: 91.17% → 95.54% (+4.4%)
20% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 54
43% less call options, than puts
Call options by funds: $1.54M | Put options by funds: $2.69M
Top Buyers
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$65.9M |
| 2 |
State Street
Boston,
Massachusetts
|
+$12.9M |
| 3 |
NAMA
Nikko Asset Management Americas
New York
|
+$11.6M |
| 4 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$11.4M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$9.2M |
Top Sellers
VCYT Hedge Fund Activity: Q1 2019 in Review
149 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q1 2019, worth a combined $983M — up 111% from $465M a quarter earlier.
Buyers outnumbered sellers: 35 funds opened new VCYT positions and 11 closed out — a net gain of 24 holders — while 43 added to existing stakes and 54 trimmed.
The largest buyer was Gilder Gagnon Howe & Co, opening a new position worth an estimated $65.9M. The largest seller was TPG Group Holdings (SBS) Advisors, cutting an estimated $52.4M.
- 149 institutional investors held Veracyte (VCYT) as of Q1 2019, up from 125 in Q4 2018.
- Funds reported $983M of Veracyte stock for Q1 2019, up 111% quarter-over-quarter.
- 35 funds opened new Veracyte positions in Q1 2019 and 11 closed out, a net change of +24 holders.
- The largest Veracyte buyer in Q1 2019 was Gilder Gagnon Howe & Co, an estimated $65.9M added.
- The largest Veracyte seller in Q1 2019 was TPG Group Holdings (SBS) Advisors, an estimated $52.4M sold.
Based on aggregated 13F filings for Q1 2019.